Padilla, Baby Girl .
HRN: 21-57-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2022
AMPICILLIN 250MG (VIAL)
07/01/2022
07/13/2022
IV
40mg
Q48h
Live Preterm Female Neonate Del Via NSVD, AS 3,5,7, BS 28-29weeks, RDS Of Prematurity, Sepsis Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes